Brentuximab vedotin and bendamustine produce long-term clinical benefit in patients with relapsed or refractory classical Hodgkin lymphoma: A multicenter real-life experience Journal Article
| Authors: | Moretti, M.; Liberati, A. M.; Rigacci, L.; Puccini, B.; Pulsoni, A.; Gini, G.; Galieni, P.; Fabbri, A.; Cantonetti, M.; Pavone, V.; Bolis, S.; Botto, B.; Renzi, D.; Falchi, L. |
| Article Title: | Brentuximab vedotin and bendamustine produce long-term clinical benefit in patients with relapsed or refractory classical Hodgkin lymphoma: A multicenter real-life experience |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 22 |
| Issue: | 3 |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2022-03-01 |
| Start Page: | 198 |
| End Page: | 204 |
| Language: | English |
| DOI: | 10.1016/j.clml.2021.09.018 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| PUBMED: | 34690088 |
| PMCID: | PMC9531864 |
| DOI/URL: | |
| Notes: | Accession Number: 155399755 -- Entry Date: In Process -- Revision Date: 20220225 -- Publication Type: Article -- Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA -- NLM UID: 101525386. -- Source: Cinahl |
